Tarsus shareholders elect four Class III directors, approve exec comp, ratify auditor

Tarsus Pharmaceuticals, Inc.

Wendy Yarno, Andrew Goldberg, Scott Morrison, David Pyott elected as Class III directors.
Advisory vote on named executive officer compensation approved with 34.5M for, 0.24M against.
Ratification of Ernst & Young as independent auditor for FY2026 approved with 38.2M for.
Meeting held June 25, 2026; 38.2M shares voted out of 43.0M outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.